Dent Neurologic

new masking policy – masks are now optional

DENTNeuro_White

RETHINK-ALZ

Simufilam 100 mg for Mild to Moderate Alzheimer’s Disease

Inclusion Criteria

  • Alzheimer’s Disease
  • **other criteria will apply

For more information, call Tatiana Jimenez-Knight at 716-961-9219 or email tjimenezknight@dentinstitute.com. You can also visit: https://rethink-alz.com/

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Scroll to Top